{"id":6749,"date":"2024-08-28T07:30:40","date_gmt":"2024-08-28T11:30:40","guid":{"rendered":"https:\/\/bridgebio.local\/news\/auto-draft\/"},"modified":"2024-08-27T16:08:48","modified_gmt":"2024-08-27T20:08:48","slug":"bridgebio-pharma-to-participate-in-september-investor-events-2","status":"publish","type":"post","link":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/","title":{"rendered":"BridgeBio Pharma to Participate in September Investor Events"},"content":{"rendered":"<p align=\"left\"><strong>PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE)<\/strong> &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of the management team will participate in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li><strong>Morgan Stanley 22<\/strong><sup><strong>nd<\/strong><\/sup><strong>\u00a0Annual Global Health Care Conference<\/strong>, New York, NY: Fireside Conversation on September 4<sup>th<\/sup>\u00a0at 10:00 am ET<\/li>\n<li><strong>Wells Fargo<\/strong>\u00a0<strong>19<\/strong><sup><strong>th<\/strong><\/sup><strong>\u00a0Annual\u00a0Healthcare Conference 2024<\/strong>, Boston, MA, September 5<sup>th<\/sup><\/li>\n<li><strong>Cantor Global Healthcare Conference<\/strong>,<strong>\u00a0<\/strong>New York, NY: Presentation on September 17<sup>th<\/sup>\u00a0at\u00a010:20 am ET<\/li>\n<\/ul>\n<p align=\"left\">To access the live webcast of BridgeBio\u2019s presentations, please visit the \u201cEvents\u201d page within the Investors section of the BridgeBio website at\u00a0<a href=\"https:\/\/investor.bridgebiodev.wpengine.com\/\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>https:\/\/investor.bridgebiodev.wpengine.com<\/u><\/strong><\/a>. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.<\/p>\n<p align=\"left\"><strong>About BridgeBio Pharma, Inc.<\/strong><\/p>\n<p align=\"left\">BridgeBio Pharma (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio\u2019s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015, and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit\u00a0<a href=\"http:\/\/www.bridgebio.local\/\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>bridgebiodev.wpengine.com<\/u><\/strong><\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/bridgebio\/\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>LinkedIn<\/u><\/strong><\/a>,\u00a0<a href=\"https:\/\/twitter.com\/BridgeBioPharma\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>Twitter<\/u><\/strong><\/a>\u00a0and\u00a0<a href=\"https:\/\/m.facebook.com\/p\/BridgeBio-Pharma-61561087329761\/?fref=mentions\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>Facebook<\/u><\/strong><\/a>.<\/p>\n<p align=\"left\"><strong>BridgeBio Contact:<\/strong><br \/>\nVikram Bali<br \/>\n<a href=\"mailto:contact@bridgebiodev.wpengine.com\" target=\"_blank\" rel=\"nofollow noopener\"><strong><u>contact@bridgebiodev.wpengine.com<\/u><\/strong><\/a><br \/>\n(650)-789-8220<\/p>\n","protected":false},"excerpt":{"rendered":"<p>PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of the management team will participate in the following upcoming investor conferences: Morgan Stanley 22nd\u00a0Annual Global Health Care Conference, New York, NY: Fireside Conversation on September 4th\u00a0at 10:00 [&hellip;]<\/p>\n","protected":false},"author":38,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8,10],"tags":[],"class_list":["post-6749","post","type-post","status-publish","format-standard","hentry","category-news","category-press-release"],"acf":{"people":false,"external_link":"","presentation":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>BridgeBio Pharma to Participate in September Investor Events - BridgeBio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BridgeBio Pharma to Participate in September Investor Events - BridgeBio\" \/>\n<meta property=\"og:description\" content=\"PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of the management team will participate in the following upcoming investor conferences: Morgan Stanley 22nd\u00a0Annual Global Health Care Conference, New York, NY: Fireside Conversation on September 4th\u00a0at 10:00 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/\" \/>\n<meta property=\"og:site_name\" content=\"BridgeBio\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-28T11:30:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-27T20:08:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Holly Condon\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:site\" content=\"@BridgeBioPharma\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Holly Condon\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/\",\"url\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/\",\"name\":\"BridgeBio Pharma to Participate in September Investor Events - BridgeBio\",\"isPartOf\":{\"@id\":\"https:\/\/bridgebio.com\/#website\"},\"datePublished\":\"2024-08-28T11:30:40+00:00\",\"dateModified\":\"2024-08-27T20:08:48+00:00\",\"author\":{\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/4add0b7d61d0ea7518a9f18377b57f96\"},\"breadcrumb\":{\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bridgebio.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BridgeBio Pharma to Participate in September Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bridgebio.com\/#website\",\"url\":\"https:\/\/bridgebio.com\/\",\"name\":\"BridgeBio\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bridgebio.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/4add0b7d61d0ea7518a9f18377b57f96\",\"name\":\"Holly Condon\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bridgebio.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/32160078eac50cc259c3cf6057162339?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/32160078eac50cc259c3cf6057162339?s=96&d=mm&r=g\",\"caption\":\"Holly Condon\"},\"url\":\"https:\/\/bridgebio.com\/author\/holly-condonbridgebio-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BridgeBio Pharma to Participate in September Investor Events - BridgeBio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/","og_locale":"en_US","og_type":"article","og_title":"BridgeBio Pharma to Participate in September Investor Events - BridgeBio","og_description":"PALO ALTO, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) &#8212; BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that members of the management team will participate in the following upcoming investor conferences: Morgan Stanley 22nd\u00a0Annual Global Health Care Conference, New York, NY: Fireside Conversation on September 4th\u00a0at 10:00 [&hellip;]","og_url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/","og_site_name":"BridgeBio","article_published_time":"2024-08-28T11:30:40+00:00","article_modified_time":"2024-08-27T20:08:48+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/bridgebio.com\/wp-content\/uploads\/2019\/02\/BridgeBio_Share.png","type":"image\/png"}],"author":"Holly Condon","twitter_card":"summary_large_image","twitter_creator":"@BridgeBioPharma","twitter_site":"@BridgeBioPharma","twitter_misc":{"Written by":"Holly Condon","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/","url":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/","name":"BridgeBio Pharma to Participate in September Investor Events - BridgeBio","isPartOf":{"@id":"https:\/\/bridgebio.com\/#website"},"datePublished":"2024-08-28T11:30:40+00:00","dateModified":"2024-08-27T20:08:48+00:00","author":{"@id":"https:\/\/bridgebio.com\/#\/schema\/person\/4add0b7d61d0ea7518a9f18377b57f96"},"breadcrumb":{"@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bridgebio.com\/news\/bridgebio-pharma-to-participate-in-september-investor-events-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bridgebio.com\/"},{"@type":"ListItem","position":2,"name":"BridgeBio Pharma to Participate in September Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/bridgebio.com\/#website","url":"https:\/\/bridgebio.com\/","name":"BridgeBio","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bridgebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/4add0b7d61d0ea7518a9f18377b57f96","name":"Holly Condon","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bridgebio.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/32160078eac50cc259c3cf6057162339?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/32160078eac50cc259c3cf6057162339?s=96&d=mm&r=g","caption":"Holly Condon"},"url":"https:\/\/bridgebio.com\/author\/holly-condonbridgebio-com\/"}]}},"_links":{"self":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/6749"}],"collection":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/comments?post=6749"}],"version-history":[{"count":0,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/posts\/6749\/revisions"}],"wp:attachment":[{"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/media?parent=6749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/categories?post=6749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bridgebio.com\/wp-json\/wp\/v2\/tags?post=6749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}